A pharmacological mouse model suggests a novel risk pathway for postpartum psychosis
article
OA: hybrid
CC0
⤵ 1 in-corpus citation
Abstract
Postpartum psychosis (PP) is a severe psychiatric disorder affecting a small proportion of new mothers shortly after childbirth. The molecular pathophysiology underlying the disorder is currently poorly understood, and there are no amenable animal models for the condition; maternal deficiency for the enzyme steroid sulfatase has been proposed as a potential risk mechanism. Here we show that inhibition of steroid sulfatase with 667-COUMATE (10mg/kg p.o.) in new mouse mothers results in behavioural abnormalities that can be partially alleviated by the administration of the clinically-efficacious antipsychotic ziprasidone (0.3-1.0mg/kg i.p.). The pattern of behavioural abnormalities in 667-COUMATE-treated mice implicated a genetic substrate at 21-23cM on chromosome 15; of the 17 genes within this chromosomal interval, only one (Nov/Ccn3) was significantly differentially expressed in the brains of vehicle and 667-COUMATE-treated mice. Two additional members of the Ccn family (Ccn2/Ctgf and Ccn4/Wisp1) were also significantly differentially expressed between the two groups, as were three further genes co-expressed with Nov/Ccn3 in brain (Arhgdig) or previously implicated in disorder risk by clinical studies (Adcy8 and Ccl2). The expression of Nov/Ccn3, but not of the other differentially-expressed genes, could be normalised by ziprasidone administration (1.0mg/kg). NOV/CCN3 lies directly under a linkage peak for PP risk at 8q24, and the associated protein possesses numerous characteristics that make it an excellent candidate mediator of PP risk. Our data suggest the 667-COUMATE-treated mouse as a model for PP with some degree of face, construct, and predictive validity, and implicate a novel, and biologically-plausible, molecular risk pathway for PP.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
References (56)
- W1025616802 via openalex
- W1487202305 via openalex
- W1530984360 via openalex
- W1546543890 via openalex
- W1551625713 via openalex
- W1830553951 via openalex
- W1930255169 via openalex
- W1972638694 via openalex
- W1998063655 via openalex
- W2002274403 via openalex
- W2013029119 via openalex
- W2016629108 via openalex
- W2022453849 via openalex
- W2025268329 via openalex
- W2039438503 via openalex
- W2043470827 via openalex
- W2050212230 via openalex
- W2054361783 via openalex
- W2054911796 via openalex
- W2057290403 via openalex
- W2059242320 via openalex
- W2061510990 via openalex
- W2065319218 via openalex
- W2067284991 via openalex
- W2068286219 via openalex
- W2073892384 via openalex
- W2087053712 via openalex
- W2089683746 via openalex
- W2090616890 via openalex
- W2102756115 via openalex
- W2111499166 via openalex
- W2128430557 via openalex
- W2131010329 via openalex
- W2132451509 via openalex
- W2137645771 via openalex
- W2141034865 via openalex
- W2143643847 via openalex
- W2144794289 via openalex
- W2149104590 via openalex
- W2154141191 via openalex
- W2154471462 via openalex
- W2155391495 via openalex
- W2158606508 via openalex
- W2160852013 via openalex
- W2164301117 via openalex
- W2178549252 via openalex
- W2215704855 via openalex
- W2228972169 via openalex
- W2313360149 via openalex
- W2401997077 via openalex
- W2496262103 via openalex
- W3000283220 via openalex
- W4239584594 via openalex
- W6638529038 via openalex
- W6664940083 via openalex
- W7006392191 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK